PetIQ (PETQ) EBIT per Share : $1.15 (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is PetIQ EBIT per Share?

PetIQ's EBIT per Share for the three months ended in Dec. 2023 was $-0.33. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.15.

During the past 12 months, the average EBIT per Share Growth Rate of PetIQ was 105.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PetIQ's EBIT per Share or its related term are showing as below:

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of PetIQ was 71.20% per year. The lowest was -4.30% per year. And the median was 39.10% per year.

PETQ's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.95
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PetIQ's EBIT for the three months ended in Dec. 2023 was $-10 Mil.

PetIQ EBIT per Share Historical Data

The historical data trend for PetIQ's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetIQ EBIT per Share Chart

PetIQ Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.14

-0.10

0.43

-0.69

1.25

PetIQ Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.06	0.54	0.63	0.31	-0.33

PetIQ EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PetIQ's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	36.913	/	29.530
=	1.25

PetIQ's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9.937	/	29.962
=	-0.33

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.15

PetIQ (NAS:PETQ) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PetIQ EBIT per Share Related Terms

Thank you for viewing the detailed overview of PetIQ's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PetIQ (PETQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PetIQ Inc (NAS:PETQ) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

39L:Germany

Address

230 East Riverside Drive, Eagle, ID, USA, 83616

Website

https://www.petiq.com

PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time were primarily available from veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment.

Executives

William J. Carter	officer: EVP, GENERAL COUNSEL	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
John Paul Pearson	officer: EVP, Services & Manufactured	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Robert Michael Herrman	officer: General Counsel and Secretary	923 SOUTH BRIDGEWAY PLACE, EAGLE ID 83616
Michael A Smith	officer: EVP - Products	923 S. BRIDGEWAY PLACE, C/O PETIQ, INC., EAGLE ID 83616
Kimberly Lefko	director	923 S. BRIDGEWAY PLACE, EAGLE ID 83616
Sheryl Oloughlin	director	923 S. BRIDGEWAY PLACE, EAGLE ID 83616
Scott Huff	director	923. S. BRIDGEWAY PLACE, EAGLE ID 83616
Allan Hall	director	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Zvi Glasman	officer: Chief Financial Officer	C/O FOX FACTORY HOLDING CORP., 915 DISC DRIVE, SCOTTS VALLEY CA 95066
Kenneth C. Walker	director	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Susan Sholtis	director	C/O PETIQ, INC., 500 E. SHORE DRIVE, SUITE 120, EAGLE ID 83616
Mccord Christensen	director, officer: Chief Executive Officer	500 EAST SHORE DRIVE, SUITE 120, EAGLE ID 83616
John Newland	officer: Chief Financial Officer	C/O TRUE SCIENCE LLC, 500 E. SHORE DRIVE SUITE 120, EAGLE ID 83616
Ronald Kennedy	director, 10 percent owner	500 EAST SHORE DR, SUITE 120, EAGLE ID 83616
Ecp Helios Partners Iv, L.p.	10 percent owner	437 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10022